These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9199260)

  • 1. Maximizing radiotracer delivery to experimental atherosclerotic lesions with high-dose, negative charge-modified Z2D3 antibody for immunoscintigraphic targeting.
    Narula J; Petrov A; Ditlow C; Pak KY; Chen FW; Khaw BA
    J Nucl Cardiol; 1997; 4(3):226-33. PubMed ID: 9199260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive localization of experimental atherosclerotic lesions with mouse/human chimeric Z2D3 F(ab')2 specific for the proliferating smooth muscle cells of human atheroma. Imaging with conventional and negative charge-modified antibody fragments.
    Narula J; Petrov A; Bianchi C; Ditlow CC; Lister BC; Dilley J; Pieslak I; Chen FW; Torchilin VP; Khaw BA
    Circulation; 1995 Aug; 92(3):474-84. PubMed ID: 7634463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma imaging of atherosclerotic lesions: the role of antibody affinity in in vivo target localization.
    Narula J; Petrov A; O'Donnell SM; Ditlow C; Pieslak I; Dilley J; Chen F; Khaw BA
    J Nucl Cardiol; 1996; 3(3):231-41. PubMed ID: 8805743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive detection of atherosclerotic lesions by 99mTc-based immunoscintigraphic targeting of proliferating smooth muscle cells.
    Narula J; Petrov A; Pak KY; Ditlow C; Chen F; Khaw BA
    Chest; 1997 Jun; 111(6):1684-90. PubMed ID: 9187194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells.
    Carrió I; Pieri PL; Narula J; Prat L; Riva P; Pedrini L; Pretolani E; Caruso G; Sarti G; Estorch M; Berná L; Riambau V; Matías-Guiu X; Pak C; Ditlow C; Chen F; Khaw BA
    J Nucl Cardiol; 1998; 5(6):551-7. PubMed ID: 9869476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging experimental atherosclerotic lesions in ApoE knockout mice: enhanced targeting with Z2D3-anti-DTPA bispecific antibody and 99mTc-labeled negatively charged polymers.
    Khaw BA; Tekabe Y; Johnson LL
    J Nucl Med; 2006 May; 47(5):868-76. PubMed ID: 16644758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.
    Tsimikas S; Palinski W; Halpern SE; Yeung DW; Curtiss LK; Witztum JL
    J Nucl Cardiol; 1999; 6(1 Pt 1):41-53. PubMed ID: 10070840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo targeting of acute myocardial infarction with negative-charge, polymer-modified antimyosin antibody: use of different cross-linkers.
    Narula J; Torchilin VP; Petrov A; Khaw S; Trubetskoy VS; O'Donnell SM; Nossiff ND; Khaw BA
    J Nucl Cardiol; 1995; 2(1):26-34. PubMed ID: 9420759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Z2D3 imaging: fringe or frontier?
    Strauss HW
    J Nucl Cardiol; 1998; 5(6):626-8. PubMed ID: 9869485
    [No Abstract]   [Full Text] [Related]  

  • 10. Smooth muscle cell proliferation index correlates with 111In-labeled antibody Z2D3 uptake in a transplant vasculopathy swine model.
    Jimenez J; Donahay T; Schofield L; Khaw BA; Johnson LL
    J Nucl Med; 2005 Mar; 46(3):514-9. PubMed ID: 15750167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting arterial wall sulfated glycosaminoglycans in rabbit atherosclerosis with a mouse/human chimeric antibody.
    Soto Y; Mesa N; Alfonso Y; Pérez A; Batlle F; Griñán T; Pino A; Viera J; Frómeta M; Brito V; Olivera A; Zayas F; Vázquez AM
    MAbs; 2014; 6(5):1340-6. PubMed ID: 25517318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
    Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
    Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vivo noninvasive detection of vulnerable atherosclerotic plaque by (99)Tc(m)-Annexin V imaging in an atherosclerotic rabbit model.].
    Xu JP; Zhao QM; Dong XL; Wang Q; Chen D; Mi HZ; DU HF; Xu ZM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Oct; 36(10):921-6. PubMed ID: 19102893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque.
    Kolodgie FD; Petrov A; Virmani R; Narula N; Verjans JW; Weber DK; Hartung D; Steinmetz N; Vanderheyden JL; Vannan MA; Gold HK; Reutelingsperger CP; Hofstra L; Narula J
    Circulation; 2003 Dec; 108(25):3134-9. PubMed ID: 14676140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoscintigraphy of atherosclerotic uncomplicated lesions in vivo with a monoclonal antibody against D-dimers of insoluble fibrin.
    Ciavolella M; Tavolaro R; Taurino M; Di Loreto M; Greco C; Sbarigia E; Casini A; Speziale F; Scopinaro F
    Atherosclerosis; 1999 Mar; 143(1):171-5. PubMed ID: 10208492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of SPECT imaging with 131I-labeled monoclonal antibody SZ39 in nude mice bearing human glioma xenografts.
    Lan Q; Huang Q; Bao S
    J Neuroimaging; 1996 Apr; 6(2):131-5. PubMed ID: 8634489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody.
    van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC
    Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and tumor targeting of 131I-labeled F(ab')2 fragments of the chimeric monoclonal antibody G250: preclinical and clinical pilot studies.
    Brouwers A; Mulders P; Oosterwijk E; Buijs W; Corstens F; Boerman O; Oyen W
    Cancer Biother Radiopharm; 2004 Aug; 19(4):466-77. PubMed ID: 15453961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution of anti-CEA F(ab')2 fragments conjugated with chelating polymers: influence of conjugate electron charge on tumor uptake and blood clearance.
    Slinkin MA; Curtet C; Faivre-Chauvet A; Sai-Maurel C; Gestin JF; Torchilin VP; Chatal JF
    Nucl Med Biol; 1993 May; 20(4):443-52. PubMed ID: 8504286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.
    Colapinto EV; Zalutsky MR; Archer GE; Noska MA; Friedman HS; Carrel S; Bigner DD
    Cancer Res; 1990 Mar; 50(6):1822-7. PubMed ID: 2407345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.